APA

Wang Z., Cheng Y., An T., Gao H., Wang K., Zhou Q., Hu Y., Song Y., Ding C., Peng F., Liang L., Hu Y., Huang C., Zhou C., Shi Y., Zhang L., Ye X., Zhang M., Chuai S., Zhu G., Hu J., Wu Y. & Wang J. (20190531). Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. : The Lancet. Respiratory medicine.

Chicago

Wang Zhijie, Cheng Ying, An Tongtong, Gao Hongjun, Wang Kai, Zhou Qing, Hu Yanping, Song Yong, Ding Cuimin, Peng Feng, Liang Li, Hu Yi, Huang Cheng, Zhou Caicun, Shi Yuankai, Zhang Li, Ye Xin, Zhang Meizhuo, Chuai Shaokun, Zhu Guanshan, Hu Jin, Wu Yi-Long and Wang Jie. 20190531. Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. : The Lancet. Respiratory medicine.

Harvard

Wang Z., Cheng Y., An T., Gao H., Wang K., Zhou Q., Hu Y., Song Y., Ding C., Peng F., Liang L., Hu Y., Huang C., Zhou C., Shi Y., Zhang L., Ye X., Zhang M., Chuai S., Zhu G., Hu J., Wu Y. and Wang J. (20190531). Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. : The Lancet. Respiratory medicine.

MLA

Wang Zhijie, Cheng Ying, An Tongtong, Gao Hongjun, Wang Kai, Zhou Qing, Hu Yanping, Song Yong, Ding Cuimin, Peng Feng, Liang Li, Hu Yi, Huang Cheng, Zhou Caicun, Shi Yuankai, Zhang Li, Ye Xin, Zhang Meizhuo, Chuai Shaokun, Zhu Guanshan, Hu Jin, Wu Yi-Long and Wang Jie. Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. : The Lancet. Respiratory medicine. 20190531.